Colleen Stinchcombe, Author at Medical Bag

Colleen Stinchcombe

Colleen Stinchcombe writes about health, science, and the environment. Her work can be found at colleenstinchcombe.com.

All articles by Colleen Stinchcombe

Physician's desk and hands

How to Make It as a Private Practice Physician

Being a physician these days is not easy, and it can feel even tougher to run one’s own private practice. One sobering survey found that 8% of practices had closed during the pandemic. But there are ways to make it work—and there’s good reason to try. Tara Scott, an OB/GYN turned hormone specialist who is…

Doctor with mask looking out window

The Stress of the Pandemic Drove These Doctors to Retirement

Stephen Rockower is an orthopedic surgeon in suburban Rockville, Maryland. He’d built his own practice for more than a decade with a partner, and things were busy and going well. Then, in March 2020, the COVID-19 pandemic shuttered many cities, including his own. Residents in his area began delaying care, not wanting to expose themselves…

2021 with coronavirus and vaccine illustration

Doctors Are ‘Guardedly Optimistic’ About 2021

Last year was “brutal, exhilarating, terrifying, awesome, and ultimately grueling” for Jonathan Golob, assistant professor of infectious disease at the University of Michigan. Around Easter, he volunteered to be part of a team handling surge capacity for the hospital’s respiratory intensive care cases, as doctors were still learning how to care for patients and effectively…

Illustration of a woman with her hands to her head

How Doctors Are Treating COVID-19 Long-Haulers

Nine months into the pandemic, it’s become clear that the effects of the disease caused by SARS-CoV-2 can last beyond the acute illness. Among COVID-19 patients 18 to 35 years old who were previously in good health, as many as 20% experience prolonged symptoms, according to the World Health Organization. Complaints among so-called long-haulers include…

U.S. Supply of COVID-19 Therapeutics Seems Stable, for Now

In September, as doctors prepared for a fall and winter COVID-19 surge across the U.S., they sounded alarms about inadequate supplies of the antiviral medication remdesivir to treat their patients. But that supply concern seems to have been addressed: Gilead, remdesivir’s U.S. manufacturer, confirmed that they are “meeting real-time, global demand” in an email to…

Next post in Features